MEDPACE

Company Overview

Medpace is a scientifically driven CRO that offers full clinical development services to pharmaceutical and biotechnology companies and medical device industries. The company is focused on the global growth of safe and effective medical therapeutics through its functioning approach. It influences regulatory and therapeutic expertise across oncology, CNS health, cardiology, endocrinology, metabolic disease, anti-viral and anti-infective.

The company operates its business via one segment that executes extensive pre-clinical, clinical testing and regulatory review. It offers full-fledged product development services for Phase I-IV clinical trials. Services are offered through several units: Medical Department, Clinical Trial Management, Data-Driven Feasibility, Study Start-Up, Patient Recruitment and Retention, Clinical Monitoring, Risk-Based Monitoring, Regulatory Affairs, Medical Writing, Biometrics and Data Sciences, Pharmacovigilance, Core Laboratory, Central Laboratory, Bioanalytical Laboratory, Clinics and Quality Assurance. The company has locations in 40 countries and more than 5,900 employees.

Financial Highlights (FY 2025)

Company's Business Segments

• Product : Clinical Trial Management, Clinical Monitoring, Clinical Packaging and Supplies, Imaging Core Lab, Others
• Service : Clinical Development Consulting, Therapeutic Expertise, Others